first a huge momo play in Sep 2021 ... now another onelikely much smaller one this time.
Very small float and o/s shares so it can be easily manipulated I guess. Just make sure to take profits because these profits will most likely not last long at all.
This is an early stage biotech company that will need lots of money to keep going. Presently they are still well financed due to the relatively recent financing upon Nasdaq listing ... but they can burn through this money fairly quickly. Time will tell.